Pictured: Vivian Strong
Cancer Guide
By Andrea Peirce, BA, Writer/Editor  |  Tuesday, June 24, 2014

Memorial Sloan Kettering diagnoses and treats more people with stomach cancer than any other cancer center in the nation.

Pictured: Larry Norton
Video
By Helen Garey, MPH, Freelance Writer  |  Tuesday, June 10, 2014

Memorial Sloan Kettering experts say that new information about the biology of breast cancer is revolutionizing the way they look at the disease.

Pictured: Jedd Wolchok
MSK at ASCO
By Media Staff  |  Wednesday, June 4, 2014

Our experts offer their perspective in major media outlets on recent research into drug- and cell-based immunotherapies for cancer.

Pictured: David Solit
Profile
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, May 27, 2014

David Solit, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, discusses how working with cancer patients drives him to develop more-effective, personalized cancer treatments.

Pictured: José Baselga, Agnès Viale,  Michael Berger & David Solit
Announcement
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, May 20, 2014

With the creation of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering sets out to deliver on the promise of personalized medicine by creating better treatment options for all people with cancer.

Pictured: William Tap
MSK at ASCO
By Media Staff  |  Thursday, May 15, 2014

New Memorial Sloan Kettering research demonstrates the powerful clinical benefit of giving patients a drug that targets the molecular abnormality driving the growth of a rare and debilitating joint disease.

Cancer Guide
By Esther Napolitano, BS, Science Writer/Editor  |  Thursday, April 17, 2014

Molecular analysis of lung tumors can help guide treatment decisions. Memorial Sloan Kettering is one of only a handful of centers nationwide to offer this personalized approach to care.

In the News
By Jennifer Bassett, MA, Senior Managing Editor & Content Strategist  |  Friday, April 11, 2014

IBM’s Watson won Jeopardy!, but what if its power could be used for the greater good to help make better cancer care choices?

Pictured: José Baselga
Announcement
By Media Staff  |  Thursday, April 10, 2014

Discoveries made at Memorial Sloan Kettering receive recognition at the 2014 Annual Meeting of the American Association for Cancer Research.

Pictured: Diane Reidy
Feature
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, February 19, 2014

Cycle for Survival, Memorial Sloan Kettering’s nationwide indoor team cycling event, helps support research into rare cancers. Three researchers discuss how these funds benefit their research.

Pictured: Low-dose CT scans
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, December 26, 2013

The American Society of Clinical Oncology’s annual report on top clinical cancer advances of the year once again features several studies led by Memorial Sloan Kettering researchers.

Pictured: Charles L. Sawyers, William Polkinghorn & Simon Powell
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, December 12, 2013

Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.

Pictured: Ross Levine
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Monday, December 9, 2013

A new diagnostic test co-developed by Memorial Sloan Kettering identifies hundreds of genetic alterations in blood cancers, which will guide physicians in treatment decisions.

Perspective
By Paul Sabbatini, MD, Deputy Physician-in-Chief for Clinical Research  |  Friday, July 26, 2013

The clinical trial remains our best tool to identify new therapies, but as with all tools, innovation is required if trials are to remain relevant.

Pictured: Mark Kris
In the News
By Media Staff  |  Tuesday, July 9, 2013

Medical oncologist Mark G. Kris and one of his patients were interviewed for a CBS This Morning segment that describes how a Memorial Sloan Kettering team trains the supercomputer IBM Watson to help doctors identify the best cancer management options for individual patients.

Center News

Stay Informed

Get the latest information about cancer care and research every month.